01—Abstract
Summary
Summary of the 8-K filed December 30, 2025. Cited figures are marked; the original filing is the authoritative source.
Labcorp Holdings Inc. (NYSE: LH) filed a Current Report on Form 8-K dated December 30, 2025, under Item 7.01 (Regulation FD Disclosure).
The filing states that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. Pacific Time.
The filing contains no financial results, guidance, or other financial metrics. A live audio webcast of the fireside chat will be available through the company's Investor Relations website at ir.Labcorp.com, and the webcast will be archived for replay. The accompanying press release, furnished as Exhibit 99.1, announces the participation and describes Labcorp as a global leader of laboratory services with nearly 70,000 employees serving clients in approximately 100 countries.
For investors, this filing is an event notice rather than a source of new financial information. Its main value is in signaling management's scheduled public appearance at a major healthcare investor conference and providing access details for the webcast.
02—Key points
Key Highlights
- Labcorp will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. PT.
- A live audio webcast of the fireside chat will be available on the Company Investor Relations website at ir.Labcorp.com, with an archived replay.
- The filing is furnished under Item 7.01 (Regulation FD Disclosure), so no financial results or guidance are reported in this 8-K.
- Exhibit 99.1 is a press release dated December 30, 2025, announcing the conference participation.
- The press release describes Labcorp as serving doctors, hospitals, pharmaceutical companies, researchers and patients, with nearly 70,000 employees and clients in approximately 100 countries.
- The press release states that Labcorp provided support for more than 75% of the new drugs and therapeutic products approved by the FDA in 2024 and performs more than 700 million tests annually.
03—Questions
Frequently Asked Questions
When and where will Labcorp's fireside chat take place?
The fireside chat will take place at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. Pacific Time.
How can investors listen to the fireside chat?
A live audio webcast will be available through the Company Investor Relations website at ir.Labcorp.com, and the webcast will be archived for replay.
Does this filing include financial results or guidance?
No. The filing is furnished under Item 7.01 (Regulation FD Disclosure) and only announces the company's participation in the conference and the webcast details. It contains no financial results, guidance, or financial metrics.
What does Labcorp's press release say about the company's scale?
The press release, filed as Exhibit 99.1, states that Labcorp has nearly 70,000 employees, serves clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved by the FDA in 2024, and performs more than 700 million tests annually.
04—Continue